Can-kai Lin is currently employed at Guangzhou Medical University, affiliated with the Key Laboratory of Molecular Targets and Clinical Pharmacology and the State Key Laboratory of Respiratory Disease (China). His research focuses on bioactive secondary metabolites of deep - sea fungi, especially polyketides, naphthoquinones, halogenated compounds, and mixed - polypropionates. He is the Principal Investigator of the "Bioactive Secondary Metabolites of Fusarium from the Shenhu Sea Area" project. His research, conducted with interdisciplinary collaborators, mainly explores the in - vitro anticancer activities of these metabolites and aims to discover potential antibiotics, while also delving into microbial epigenetics.